pharmaceutical industrytherapeuticsbioethicsJeffrey PeppercornDuke University Division of Medical Oncology Durham North CarolinaThomas G. RobertsNoonday Asset Management L.P., Charlotte North CarolinaTim G. HammondDepartment of Safety Pharmacology, AstraZeneca, Macclesfield Cheshire UK...
The science of clinical pharmacology provides the backbone for the methodologies developed and implemented across the pharmaceutical industry to improve the odds of success and address the challenges of “getting the dose right.” Clinical pharmacologists contribute their ability to integrate basic and ...
Master’s degree with 1+ years pharmaceutical industry or clinical medicine experience; prefer clinical research/development experience Knowledge of regulatory requirements and GCPs 以担保或任何理由索取财物,扣押证照,均涉嫌违法,请提高警惕
It is worth to point out that some technical problems still need to be addressed for efficient and effective technology transfer of the 3D bioprinted platform for advanced drug discovery and development in the pharmaceutical industry. Therefore, the critical aspects of the current requirements to valid...
Can the pharmaceutical industry reduce attrition rates? Nat. Rev. Drug Discov. 3, 711–715 (2004). Article CAS Google Scholar Abrantes-Metz, R., Adams, C. & Metz, A. Pharmaceutical Development Phases: A Duration Analysis. Working paper no. 274. http://www.ftc.gov/be/workpapers/wp...
In recent years, the pharmaceutical industry has seen tremendous changes in the way it is expected to deliver new drugs to market: being under increasing pressure to expedite the development of new therapies,to decrease clinical study duration, and to drive new treatments through their clinical ...
The traditional clinical development model needs to change. Decentralised clinical trials With the rising cost and time to bring new drugs to market, the demand for decentralised and hybrid trials has steadily risen. Blended solutions Pharmaceutical sponsors need agile, adaptable outsourcing models that ...
Partnering with us opens the door to some of the industry’s most accomplished leaders, who put your project — and you — first. Individually, we have decades of development, manufacturing, packaging and clinical supply chain experience. As a team, we are redefining the way pharmaceutical ...
The report recommends preregistration of studies as a condition for publication, so that pharmaceutical companies can't cherry-pick their results. The “sponsorship effect” is active in drug development for osteoporosis treatments and may have contributed to today's landscape of dangerous and ineffecti...
Declining pharmaceutical industry productivity is well recognized by drug developers, regulatory authorities and patient groups. A key part of the problem is that clinical studies are increasingly expensive, driven by the rising costs of conducting Phase II and III trials. It is therefore crucial to ...